You searched for:
Remove constraint Funder: Roche Vitamins Ltd.
Roche Vitamins Ltd.
- British Heart Foundation2
- Medical Research Council2
- Roche Vitamins Ltd.[remove]2
- Merck & Co.1
- Merck and Co.1
Email search results
1 - 2 of 2
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
- Emberson, JR, Ng, L, Armitage, J, et al.
Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
- Heart Protection Study Collaborative Group